ES / EN
- September 1, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba Economy Cuban Economy

Cuban biotechnology

by
  • Mónica Rivero
    Mónica Rivero,
  • monica-rivero
    monica-rivero
August 12, 2014
in Cuban Economy
0
Foto: Trabajadores.

Foto: Trabajadores.

BioCubaFarma aims at exporting about 5 076 million dollars in the next five years. This Group of Biotechnological and Pharmaceutical Industries was founded in November 2012 and is in charge of the processing of materials by biological agents for producing medicines, equipment and high technological services for improving the population’s health and the generation of exportable goods and services in the current Cuban context.

The Group is made up of 38 large companies comprising 21 613 workers. It emerged from the fusion of Quimefa, an enterprise for the production of medicines, and the Biotechnology Scientific Pole, leading institutions in this field in Cuba.

According to Dr. Agustin Lage, general director of the Molecular Immunology Center, BioCubaFarma’s main challenges are:

– To grow, rely on permanent investment capacities, reach international quality standards (which are not static), diversify exports with a commercial strategy up to par with this purpose, guarantee the constant renovation of products.

Disadvantages

– Scarce resources, industrial underdevelopment, economic blockade, high migration rates of qualified personnel, deteriorated work and life conditions, objective limitations in the use of TICs and connectivity and internet access.

Related Posts

Streets of Old Havana with the Capitol in the background

Notes on our circumstances

July 20, 2025
xr:d:DAFlLH53xAU:282,j:1521492641457684093,t:23090415

Government authorizes representation in Cuba of five more foreign companies, one from the U.S.

June 21, 2025
Cuban Architecture. Crisis in Cuba

A permanent congress of Cuban economists and accountants

June 14, 2025
Havana Cathedral. Cuba’s main economic partners

Who are Cuba’s main economic partners?

May 31, 2025

In view of this context, the development strategy by the Cuban biotechnological sector can be summarized as follows:

– Strong governmental investments, Support in Cuban scientists and professionals, Closed cycle strategy: from research to post-commercialization monitoring, National cooperation: coordination among research and development institutions and those implementing results, Integration of institutions:

Research+Development+Production+Commercialization, View of Biotechnology as part of the Cuban Health System, National market as priority, Interest in gaining in international competitiveness: quality, production volumes, costs, news, joint ventures; High investments in education and training of human resources.

The implementation of this formula has represented an exponential increase of production rates in a couple decades. In 2011, Cuba had most extensive and intense vaccination program (13 vaccines). The Scientific Pole in the West of the Capital, founded in the early 80’s, owns more than 900 patents abroad and some of them have been recognized with a Medal by the Copyright World Organization.

Biofarmacuba: number of products approved
Biofarmacuba: number of products approved

 

 

The Cuban industry in this field is spread throughout 58 nations in the world and has created joint ventures with some of them.

Biocubafarma: Countries that have granted patents
Biocubafarma: Countries that have granted patents

Even though the national market is top priority, there are difficulties in terms of:

Deficiencies in:

– The distribution of medicines for supplying the population and in its organization and legal aspects
Failures in:

-Imports, investments, quality of the services

Some of the achievements of Cuban biotechnology are:

– First therapeutic vaccine for the treatment of advanced lung cancer(CIMAVAX EGF); also useful in head and neck, brain, gastric, breast, rectal, prostate, neck of the womb, bladder, ovary and pancreas cancer.

– Vaccines against hepatitis B; antimeningococcica type B (VA-MENGOC-BC), unique in its kind in the world; against tetanus, leptospirosis and typhoid fever; against meningitis B and C, and a therapeutic vaccine against all varieties of dengue.

– Immunization against Haemophilusinfluenzae, the first synthetic vaccine in the world.

– Interferon against cirrhosis of the liver and liver cancer.

– Heberprot-P, the single medicine in the world which speeds up the healing of diabetic foot ulcers and reduces the risk of amputation of the limbs.

– Substances that can fight malignant tumors: Vidatox, made from scorpion venom, and CimaVax, the first therapeutic vaccine against lung cancer.
– More than one hundred monoclonal antibodies.

– Diagnosis systems for diseases such as HIV-AIDS and lipoprotein (a).

– Skin growth factor.

– Medical equipment and computer programs.

Biocubafarma: Incomes
Biocubafarma: Incomes

 

Policies for the negotiation of projects by the Center of Genetic Engineering and Biotechnology (CIGB by its acronym in Spanish):

– Each project will be subjected to independent negotiation.

– After apotential counterpart expresses its intention of starting negotiations, a confidentiality agreement will be signed (if required) prior to the exchange of additional sensitive information on the subject of work.

– A negotiation team, prepared for discussing thoroughly the state of technology or research, status of patents, financial requirements, competence status, market estimations, work schedule and risks will be appointed for each project.

– In general, the agreement must lead the counterparts to share the project’s development costs in accordance with a pre-established payment structure.

– The Cuban counterpart tangible assets or productionfacilities, pilot or research, belonging to the Cuban State are ruled out of all kinds of negotiations.

– Out of this exception, the rest of the negotiation terms will be analyzed and agreed in a flexible and mutual understanding environment.

Projects in progress:

– Therapeutic vaccine against hepatitis B, Vaccine against hepatitis C, Recombining vaccine against dengue, AIDS vaccine, Therapeutic vaccine against cervix cancer, Cancer immunotherapy, Identification of cell targets of inhibition of HIV, Autoimmunity, Design of antiviral molecules against HIV.

The Cuban biotechnological industry demands competition in first world markets. They are working on the development of several vaccines and on different projects for others with commercial purposes and are –relatively– close to materializing.

  • Mónica Rivero
    Mónica Rivero,
  • monica-rivero
    monica-rivero
Previous Post

Higinio

Next Post

Kerry and the Illusion of a Monroe Doctrine

Mónica Rivero

Mónica Rivero

monica-rivero

monica-rivero

Next Post

Kerry and the Illusion of a Monroe Doctrine

Since Marabana was first held in 1987 few American runners have been able to participate in the race / Photo: INDER.

US Marathon runner can participate in Marabana

Cuba ... a stronghold of heavy metal?

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • The Enchanted Shrimp of the Cuban Dance

    3206 shares
    Share 1282 Tweet 802
  • Tourism and hotel leasing in Cuba. A valid option?

    6 shares
    Share 2 Tweet 2
  • September to see 20% drop in air connections between U.S. and Cuba

    6 shares
    Share 2 Tweet 2
  • What happened to cooperatives in Cuba? A review after more than a decade of “updating”

    6 shares
    Share 2 Tweet 2
  • Martí in Manhattan, a symbol that returns the gaze

    6 shares
    Share 2 Tweet 2

Most Commented

  • Jacqueline Maggi: “I learned to do with my hands what I could, with what I had and where life would take me”

    40 shares
    Share 16 Tweet 10
  • Yuma: my no place of distances and affections

    13 shares
    Share 5 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}